RT

RTA LABORATUVARLARI BİYOLOJİK ÜRÜNLER İLAÇ VE MAKİNE SANAYİ TİCARET A.Ş.

Develops and produces IVD kits and biological pharmaceuticals for the healthcare sector.

RTALB | IS

Overview

Corporate Details

ISIN(s):
TRERTAL00018
LEI:
Country:
Türkiye
Address:
N/A
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

RTA Laboratuvarları, established in 1996, is a biotechnology company specializing in the research, development, and production of in-vitro diagnostic (IVD) products and biological pharmaceuticals. The company focuses on the fields of molecular biology and microbiology, utilizing its advanced R&D laboratories and expert personnel to develop a wide range of diagnostic kits and related biological materials. Its core activities include the production and distribution of domestic diagnostic solutions for the healthcare sector, with specific product lines in molecular biology, microbiology, and COVID-19 diagnostics. The company is committed to innovation and development in the molecular biotechnology field.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-27 16:10
Annual / Quarterly Financial Statement
Sorumluluk Beyanı (30.09.2025)
Turkish 21.9 KB
2025-10-27 16:10
Quarterly Report
Faaliyet Raporu (30.09.2025)
Turkish 848.8 KB
2025-10-27 16:10
Report Publication Announcement
Faaliyet Raporu (30.09.2025)
Turkish 11.2 KB
2025-10-27 16:10
Quarterly Report
Financial Report
Turkish 1.9 MB
2025-10-27 16:10
Annual / Quarterly Financial Statement
Financial Report
English 2.5 MB
2025-08-11 17:10
Environmental & Social Information
Participation Finance Principles Information Form
English 52.9 KB
2025-08-08 18:55
Annual / Quarterly Financial Statement
Sorumluluk Beyanı (30.06.2025)
Turkish 21.9 KB
2025-08-08 18:55
Interim Report
Faaliyet Raporu (30.06.2025)
Turkish 902.6 KB
2025-08-08 18:55
Report Publication Announcement
Faaliyet Raporu (30.06.2025)
Turkish 11.2 KB
2025-08-08 18:55
Interim Report
Financial Report
Turkish 1.9 MB
2025-08-08 18:55
Annual / Quarterly Financial Statement
Financial Report
English 2.5 MB
2025-07-07 11:10
Post-Annual General Meeting Information
2025 Yılı Bağımsız Denetim Şirketi Seçiminin Tescili ve İlanı
Turkish 29.4 KB
2025-07-07 11:08
Post-Annual General Meeting Information
2. Olağan Genel Kurulu Tescil ve İlanı
Turkish 414.9 KB
2025-07-07 11:08
Post-Annual General Meeting Information
2. Olağan Genel Kurulu Tescil ve İlanı
Turkish 672.0 KB
2025-07-07 11:08
Pre-Annual General Meeting Information
2. Olağan Genel Kurulu Tescil ve İlanı
Turkish 14.5 KB

Automate Your Workflow. Get a real-time feed of all RTA LABORATUVARLARI BİYOLOJİK ÜRÜNLER İLAÇ VE MAKİNE SANAYİ TİCARET A.Ş. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for RTA LABORATUVARLARI BİYOLOJİK ÜRÜNLER İLAÇ VE MAKİNE SANAYİ TİCARET A.Ş.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for RTA LABORATUVARLARI BİYOLOJİK ÜRÜNLER İLAÇ VE MAKİNE SANAYİ TİCARET A.Ş. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Tourmaline Bio, Inc. Logo
Develops an anti-IL-6 antibody for cardiovascular, inflammatory, and immune diseases.
United States of America
TRML
TOWA PHARMACEUTICAL CO.,LTD. Logo
Manufactures and markets high-quality, accessible generic drugs for various therapeutic areas.
Japan
4553
Transcode Therapeutics, Inc. Logo
Develops targeted RNA therapies for metastatic cancer using a proprietary nanoparticle delivery platform.
United States of America
RNAZ
Travere Therapeutics, Inc. Logo
Develops therapies for rare kidney and metabolic diseases, with an FDA-approved treatment for IgA nephropathy.
United States of America
TVTX
Traws Pharma, Inc. Logo
Develops oral small-molecule therapies for respiratory viral diseases and cancer.
United States of America
TRAW
TScan Therapeutics, Inc. Logo
Developing TCR-engineered T-cell therapies for solid and hematologic cancers.
United States of America
TCRX
TSUMURA & CO. Logo
A leader in Japanese Kampo herbal medicine, producing prescription and OTC formulations.
Japan
4540
TuHURA Biosciences, Inc./NV Logo
Phase 3 immuno-oncology firm developing therapeutics to overcome cancer therapy resistance.
United States of America
HURA
TURK İLAÇ VE SERUM SANAYİ A.Ş. Logo
Turkish producer of pharmaceuticals, specializing in IV solutions and vaccines for hospitals.
Türkiye
TRILC
Tvardi Therapeutics, Inc. Logo
Developing oral STAT3 inhibitors to treat cancers and fibrosis-driven diseases.
United States of America
TVRD

Talk to a Data Expert

Have a question? We'll get back to you promptly.